Carolin Jakob

432 total citations
15 papers, 87 citations indexed

About

Carolin Jakob is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Carolin Jakob has authored 15 papers receiving a total of 87 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Carolin Jakob's work include COVID-19 Clinical Research Studies (6 papers), Neutropenia and Cancer Infections (4 papers) and Cancer survivorship and care (3 papers). Carolin Jakob is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), Neutropenia and Cancer Infections (4 papers) and Cancer survivorship and care (3 papers). Carolin Jakob collaborates with scholars based in Germany. Carolin Jakob's co-authors include Jörg Janne Vehreschild, Stefan Borgmann, Michael Hallek, Kai Wille, Melanie Stecher, Annika Y. Claßen, Siegbert Rieg, Tamina Seeger‐Nukpezah, Lisa Pilgram and Lukas Tometten and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and BMC Cancer.

In The Last Decade

Carolin Jakob

14 papers receiving 84 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolin Jakob Germany 6 34 27 24 18 15 15 87
Lisa Pilgram Germany 6 39 1.1× 12 0.4× 20 0.8× 10 0.6× 14 0.9× 15 83
Ellen Cusano Canada 8 48 1.4× 14 0.5× 26 1.1× 6 0.3× 20 1.3× 15 153
Romein W. G. Dujardin Netherlands 4 40 1.2× 24 0.9× 13 0.5× 10 0.6× 19 1.3× 9 81
Aaron Jamison United Kingdom 7 29 0.9× 12 0.4× 15 0.6× 25 1.4× 10 0.7× 19 116
Lauren A. Decker United States 5 60 1.8× 42 1.6× 27 1.1× 11 0.6× 25 1.7× 6 125
Özgür Merhametsiz Türkiye 6 47 1.4× 14 0.5× 26 1.1× 7 0.4× 10 0.7× 14 92
Paula L. Kip United States 6 65 1.9× 9 0.3× 17 0.7× 9 0.5× 8 0.5× 14 99
Jos A. H. van Oers Netherlands 6 32 0.9× 9 0.3× 20 0.8× 6 0.3× 34 2.3× 12 77
Matthieu Turpin France 5 34 1.0× 14 0.5× 13 0.5× 8 0.4× 17 1.1× 14 85
Sharon Nirenberg United States 6 48 1.4× 23 0.9× 16 0.7× 10 0.6× 9 0.6× 11 104

Countries citing papers authored by Carolin Jakob

Since Specialization
Citations

This map shows the geographic impact of Carolin Jakob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolin Jakob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolin Jakob more than expected).

Fields of papers citing papers by Carolin Jakob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolin Jakob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolin Jakob. The network helps show where Carolin Jakob may publish in the future.

Co-authorship network of co-authors of Carolin Jakob

This figure shows the co-authorship network connecting the top 25 collaborators of Carolin Jakob. A scholar is included among the top collaborators of Carolin Jakob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolin Jakob. Carolin Jakob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Riedel, Richard, Lucia Nogová, Sebastian Michels, et al.. (2025). MET-Driven Resistance to Sotorasib in KRAS G12C–Mutant NSCLC and Response to Combined KRAS and MET Inhibition. JTO Clinical and Research Reports. 7(3). 100925–100925.
2.
Mahajan, Ujjwal Mukund, Johanna Erber, Florian Voit, et al.. (2023). Validation of the SACOV-19 score for identifying patients at risk of complicated or more severe COVID-19: a prospective study. Infection. 51(6). 1669–1678. 1 indexed citations
3.
Hanses, Frank, Melanie Stecher, Michael Dreher, et al.. (2022). COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry. United European Gastroenterology Journal. 10(4). 409–424. 8 indexed citations
4.
Kleineberg, Nina N., Samuel Knauß, Eileen Gülke, et al.. (2021). Neurological implications of COVID-19-results of the LEOSS registry. European Journal of Neurology. 28. 101–102. 1 indexed citations
5.
Pilgram, Lisa, Lukas Eberwein, Kai Wille, et al.. (2021). Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease. Infection. 49(4). 725–737. 12 indexed citations
6.
Taubert, Max, Tamina Seeger‐Nukpezah, Ulrich Jaehde, et al.. (2021). Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients. BMC Cancer. 21(1). 719–719. 20 indexed citations
7.
Jakob, Carolin, Annika Y. Claßen, Melanie Stecher, et al.. (2021). Association between the dietary regimen and infection-related complications in neutropenic high-risk patients with cancer. European Journal of Cancer. 155. 281–290. 7 indexed citations
8.
Rieder, Marina, Klaus Kaier, Carolin Jakob, et al.. (2021). Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities. Clinical Research in Cardiology. 111(3). 322–332. 5 indexed citations
9.
Pilgram, Lisa, Maximilian Schons, Carolin Jakob, et al.. (2021). Die COVID-19 Pandemie als Herausforderung und Chance für Register in der Versorgungsforschung: Erfahrungen aus Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS). Das Gesundheitswesen. 83(S 01). S45–S53. 7 indexed citations
10.
Cremer, Sebastian, Carolin Jakob, Alexander Berkowitsch, et al.. (2020). Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry. Clinical Research in Cardiology. 110(7). 1029–1040. 18 indexed citations
11.
Jakob, Carolin, Sebastian Heimann, Annika Y. Claßen, et al.. (2019). 2474. The 10 Years Scientific Contribution of the Cologne Cohort of Neutropenic Patients (CoCoNut) for Evaluating Treatment and Outcome of Healthcare-associated Infections. Open Forum Infectious Diseases. 6(Supplement_2). S857–S857. 1 indexed citations
12.
Jakob, Carolin, Annika Y. Claßen, Melanie Stecher, et al.. (2019). 2187. Prediction of Patient Outcome During Febrile Neutropenia Despite Anti-infective Treatment Using Machine Learning Algorithms. Open Forum Infectious Diseases. 6(Supplement_2). S744–S744. 3 indexed citations
13.
Lorenz, W., et al.. (2005). Implementing a clinical pathway for quality-of-life diagnostics and therapy in follow-up of breast cancer patients. Journal of Clinical Oncology. 23(16_suppl). 758–758. 2 indexed citations
14.
Klinkhammer‐Schalke, Monika, et al.. (2005). Enhancing the status of quality-of-life diagnostics in caring for breast cancer patients: Results from a multilevel implementation study in a regional tumor centre. Journal of Clinical Oncology. 23(16_suppl). 659–659. 1 indexed citations
15.
Jakob, Carolin, Michael Wagner, Torsten Hothorn, et al.. (2004). Web-basiertes Training in der Radiologie - Studentenkurs in der Virtuellen Hochschule Bayern (VHB). RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 176(6). 885–895. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026